Press releases
Forward Pharma Agrees to Enter Into Settlement and License Agreement...
Biogen will pay Forward a non-refundable cash fee of $1.25 billion Forward may be eligible to receive royalties of 10% of net sales of Tecfidera... read more
17.01.2017 • By Forward Pharma A/S